ATG16L1 deficiency in macrophages drives clearance of uropathogenic E. coli in an IL-1β-dependent manner

Mucosal Immunology - Tập 8 - Trang 1388-1399 - 2015
J W Symington1, C Wang1, J Twentyman1, N Owusu-Boaitey1, R Schwendener2, G Núñez3, J D Schilling4,5,6, I U Mysorekar1,6
1Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, Missouri, USA
2Laboratory of Liposome Research, Institute of Molecular Cancer Research, Zurich, Switzerland
3Department of Pathology and Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, USA
4Diabetic Cardiovascular Disease Center, Washington University School of Medicine, St. Louis, Missouri, USA
5Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.
6Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA

Tài liệu tham khảo

Dielubanza, 2011, Urinary tract infections in women, Med. Clin. North Am., 95, 27, 10.1016/j.mcna.2010.08.023 Foxman, 2014, Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden, Infect. Dis. Clin. North Am., 28, 1, 10.1016/j.idc.2013.09.003 Song, 2008, Innate and adaptive immune responses in the urinary tract, Eur. J. Clin. Invest., 38, 21, 10.1111/j.1365-2362.2008.02005.x Schilling, 2003, Toll-like receptor 4 on stromal and hematopoietic cells mediates innate resistance to uropathogenic Escherichia coli, Proc. Natl. Acad. Sci. USA, 100, 4203, 10.1073/pnas.0736473100 Ulett, 2013, Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection, Curr. Opin. Microbiol., 16, 100, 10.1016/j.mib.2013.01.005 Billips, 2007, Modulation of host innate immune response in the bladder by uropathogenic Escherichia coli, Infect. Immun., 75, 5353, 10.1128/IAI.00922-07 Hunstad, 2005, Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli, Infect. Immun., 73, 3999, 10.1128/IAI.73.7.3999-4006.2005 Loughman, 2011, Attenuation of human neutrophil migration and function by uropathogenic bacteria, Microb Infect. / Institut Pasteur, 13, 555, 10.1016/j.micinf.2011.01.017 Bauckman, K.A., Owusu-Boaitey, N. & Mysorekar, I.U. Selective autophagy: Xenophagy. Methods 10.1016/j.ymeth.2014.12.005 (2014). Levine, 2011, Autophagy in immunity and inflammation, Nature, 469, 323, 10.1038/nature09782 Deretic, 2013, Autophagy in infection, inflammation and immunity, Nat. Rev. Immunol., 13, 722, 10.1038/nri3532 Hampe, 2007, A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1, Nat. Genet., 39, 207, 10.1038/ng1954 Rioux, 2007, Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis, Nat. Genet., 39, 596, 10.1038/ng2032 Broz, 2011, Molecular mechanisms of inflammasome activation during microbial infections, Immunol. Rev., 243, 174, 10.1111/j.1600-065X.2011.01041.x Saitoh, 2008, Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production, Nature, 456, 264, 10.1038/nature07383 Harris, 2011, Autophagy controls IL-1beta secretion by targeting pro-IL-1beta for degradation, J. Biol. Chem., 286, 9587, 10.1074/jbc.M110.202911 Sorbara, 2013, The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner, Immunity, 39, 858, 10.1016/j.immuni.2013.10.013 Lapaquette, 2012, Defects in autophagy favour adherent-invasive Escherichia coli persistence within macrophages leading to increased pro-inflammatory response, Cell. Microbiol., 14, 791, 10.1111/j.1462-5822.2012.01768.x Cadwell, 2008, A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells, Nature, 456, 259, 10.1038/nature07416 Cadwell, 2010, Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine, Cell, 141, 1135, 10.1016/j.cell.2010.05.009 Wang, 2012, Atg16L1 deficiency confers protection from uropathogenic Escherichia coli infection in vivo, Proc. Natl. Acad. Sci. USA, 109, 11008, 10.1073/pnas.1203952109 Schilling, 2012, Macrophages modulate cardiac function in lipotoxic cardiomyopathy, Am. J. Physiol Heart Circ. Physiol., 303, H1366, 10.1152/ajpheart.00111.2012 Zeisberger, 2006, Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach, Br. J. Cancer, 95, 272, 10.1038/sj.bjc.6603240 Engel, 2006, Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance, Infect. Immun., 74, 6100, 10.1128/IAI.00881-06 Blattner, 1997, The complete genome sequence of Escherichia coli K-12, Science, 277, 1453, 10.1126/science.277.5331.1453 Lloyd, 2007, Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli, J. Bacteriol., 189, 3532, 10.1128/JB.01744-06 Franchi, 2012, Sensing and reacting to microbes through the inflammasomes, Nat. Immunol., 13, 325, 10.1038/ni.2231 Latz, 2013, Activation and regulation of the inflammasomes, Nat. Rev. Immunol., 13, 397, 10.1038/nri3452 Travassos, 2010, Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry, Nat. Immunol., 11, 55, 10.1038/ni.1823 Carneiro, 2013, The Interplay between NLRs and Autophagy in Immunity and Inflammation, Front. Immunol., 4, 361, 10.3389/fimmu.2013.00361 Kayagaki, 2011, Non-canonical inflammasome activation targets caspase-11, Nature, 479, 112, 10.1038/nature10558 Miao, 2010, Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome, Proc. Natl. Acad. Sci. USA, 107, 3076, 10.1073/pnas.0913087107 Sauer, 2011, Listeria monocytogenes engineered to activate the Nlrc4 inflammasome are severely attenuated and are poor inducers of protective immunity, Proc. Natl. Acad. Sci. USA, 108, 12419, 10.1073/pnas.1019041108 Miao, 2010, Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria, Nat. Immunol., 11, 1136, 10.1038/ni.1960 Harder, 2009, Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor, J. Immunol., 183, 5823, 10.4049/jimmunol.0900444 Hornung, 2008, Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization, Nat. Immunol., 9, 847, 10.1038/ni.1631 Davis, 2011, The inflammasome NLRs in immunity, inflammation, and associated diseases, Annu. Rev. Immunol., 29, 707, 10.1146/annurev-immunol-031210-101405 Weber, 2014, Lysosomes integrate metabolic-inflammatory cross-talk in primary macrophage inflammasome activation, J. Biol. Chem., 289, 9158, 10.1074/jbc.M113.531202 de Luca, 2014, IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans, Proc. Natl. Acad. Sci. USA, 111, 3526, 10.1073/pnas.1322831111 Marchiando, 2013, A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection, Cell Host Microbe, 14, 216, 10.1016/j.chom.2013.07.013 Starr, 2012, Selective subversion of autophagy complexes facilitates completion of the Brucella intracellular cycle, Cell Host Microbe, 11, 33, 10.1016/j.chom.2011.12.002 Wang, 2014, NOD2 is dispensable for ATG16L1 deficiency-mediated resistance to urinary tract infection, Autophagy, 10, 331, 10.4161/auto.27196 Bokil, 2011, Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages, Immunobiology, 216, 1164, 10.1016/j.imbio.2011.05.011 Sims, 2010, The IL-1 family: regulators of immunity, Nat. Rev. Immunol., 10, 10, 10.1038/nri2691 Lee, 2012, Autophagy suppresses interleukin-1beta (IL-1beta) signaling by activation of p62 degradation via lysosomal and proteasomal pathways, J. Biol. Chem., 287, 4033, 10.1074/jbc.M111.280065 Plantinga, 2011, Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2, Gut, 60, 1229, 10.1136/gut.2010.228908 Buffen, 2013, Autophagy modulates Borrelia burgdorferi-induced production of interleukin-1beta (IL-1beta), J. Biol. Chem., 288, 8658, 10.1074/jbc.M112.412841 Ingersoll, 2008, G-CSF induction early in uropathogenic Escherichia coli infection of the urinary tract modulates host immunity, Cell. Microbiol., 10, 2568, 10.1111/j.1462-5822.2008.01230.x Lassen, 2014, Atg16L1 T300A variant decreases selective autophagy resulting in altered cytokine signaling and decreased antibacterial defense, Proc. Natl. Acad. Sci. USA, 111, 7741, 10.1073/pnas.1407001111 Murthy, 2014, A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3, Nature, 506, 446, 10.1038/nature13044 Kostic, 2014, The microbiome in inflammatory bowel disease: current status and the future ahead, Gastroenterology, 146, 1489, 10.1053/j.gastro.2014.02.009 Hung, 2009, A murine model of urinary tract infection, Nat. Protoc., 4, 1230, 10.1038/nprot.2009.116